Ketamine Research Library
Eight landmark studies that shaped the modern understanding and clinical use of ketamine - explained in plain language, with honest framing of limitations.
The foundational study showing ketamine could produce antidepressant effects within hours rather than weeks - launching two decades of research.
The widely-cited replication that made TRD the primary indication for ketamine research and clinical use.
One of the most-cited mechanistic studies linking ketamine's behavioral effects to specific cellular processes in the prefrontal cortex.
Opened the door for ketamine research beyond depression, particularly in trauma-related disorders.
One of the trials supporting FDA approval of esketamine (Spravato) in 2019, the first new mechanistic class of antidepressant in decades.
Helped establish ketamine's potential role for rapid reduction of suicidal ideation - a major unmet need in psychiatry.
The conceptual basis for how clinics design ketamine session playlists today.
Helped shape the now-common clinical practice of multi-session induction followed by maintenance dosing.
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.